Get in Touch

We helped an early stage biotech with their search strategy for a co-development partner for their CAR-T platform​

  • Access Strategy
P4A helped us think big….they gave me the confidence to find a partner for our CAR-T platform instead of targeting a partner for our 1st planned indication only​
Chief Executive Officer​

Client Challenge

Identify parties willing to enter ​into a co-development deal with ​an early stage biotech developing ​2nd generation allo. CAR-Ts

The biotech had early clinical proof of concept data and now needed a partner to fund ​further development of their 2nd generation CAR-T platform that could be adapted ​for use in multiple oncology indications​

It was essential to find potential partners willing to engage with a transformational CAR-T with only limited clinical proof of concept data

P4A Solution

P4A worked closely with the client to define the partner search criteria and develop a shortlist of potentially willing parties ​

P4A followed a structured approach grounded in ​secondary research and with frequent client touchpoints ​to ensure alignment throughout the engagement​
  • Workshop agree on a detailed set of partner search criteria​
  • An initial partner shortlist was developed​
  • P4A conducted early, blinded engagements with BD&L personnel in the shortlisted companies to gauge ​ willingness and refine the initial shortlist  ​
  • Developed a outreach plan to further qualify partners ​

The Successful Outcome​

  • With a view to speeding up development timelines and addressing unmet need, P4A made a case to pursue a co-development partner for the entire CAR-T platform and across indications​
  • Developed an initial list of 25 potential partners which were then filtered down to 6 potential partners based on their willingness to engage on a very early asset with limited data​
  • Identified ways to optimally communicate (oral and written) ​ the aspirational value of the CAR-T platform to potential partners ​
  • Identified pragmatic evidence ‘nice-to-haves’ to make the asset more attractive to potential partners​

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

get in touch

Explore other case studies

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Price Optimisation, Access Strategy
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

  • Aramislaan 88,
  • 6213BV Maastricht, Netherlands
  • +31 6 55 88 71 96
  • contact@partners4access.com

P4A Services

For all access and Rare Disease related overview enquiries